OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial - Concepedia

Concepedia

Publication | Closed Access

OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial

328

Citations

18

References

2016

Year

Victor W. Νitti, Roger R. Dmochowski, Sender Herschorn, Peter K. Sand, Catherine Thompson, Christopher Nardo, Xiaohong Yan, Cornelia Haag‐Molkenteller

The Journal of Urology

Abstract

OnabotulinumtoxinA 100 U showed significant, clinically relevant improvement in all overactive bladder symptoms and health related quality of life in patients inadequately treated with anticholinergics and was well tolerated.

References

	Year	Citations

Page 1